(redirected from Hydromorphone Hydrochloride Extended-Release)
HHERHydromorphone Hydrochloride Extended-Release (pharmacology)
References in periodicals archive ?
15 December 2010 - US Watson Pharmaceuticals Inc (NYSE: WPI) said yesterday that its subsidiary, Watson Laboratories Inc - Florida, filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.
Watson's Hydromorphone Hydrochloride Extended-release Tablets are a generic version of Mallinckrodt Inc's Exalgo tablets, which are indicated for once daily administration for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.